Structured Review

Durect Corporation 2ml2 osmotic minipumps
2ml2 Osmotic Minipumps, supplied by Durect Corporation, used in various techniques. Bioz Stars score: 88/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2ml2 osmotic minipumps/product/Durect Corporation
Average 88 stars, based on 3 article reviews
Price from $9.99 to $1999.99
2ml2 osmotic minipumps - by Bioz Stars, 2020-07
88/100 stars

Related Products / Commonly Used Together

minipumps

Images

Related Articles

other:

Article Title: The Anti-(+)-Methamphetamine Monoclonal Antibody mAb7F9 Attenuates Acute (+)-Methamphetamine Effects on Intracranial Self-Stimulation in Rats
Article Snippet: Rats were then implanted s.c. with Alzet 2ML2 osmotic minipumps (Durect, Cupertino, CA) delivering a 7-day continuous infusion of either saline (SAL) or 10 mg/kg/day METH using the general procedures described in [ , ].

Article Title: The Effects of Irisin on Nω-Nitro-L-arginine Methyl Ester Hydrochloride-Induced Hypertension in Rats
Article Snippet: After one week, minipumps were replaced with ALZET 2ML2 osmotic minipumps containing irisin (Phoenix Pharmaceuticals, USA; 50 nmol/day) for two weeks.

Article Title: The Effects of Irisin on Nω-Nitro-L-arginine Methyl Ester Hydrochloride-Induced Hypertension in Rats
Article Snippet: After one week, minipumps were replaced with ALZET 2ML2 osmotic minipumps containing irisin (50 nmol/day) for two weeks.

Article Title: Comparison of the behavioral effects of cigarette smoke and pure nicotine in rats
Article Snippet: Rats were then implanted s.c. with Alzet 2ML2 osmotic minipumps (Durect, Cupertino, CA) delivering a continuous infusion of either saline (Group 1) or nicotine (3.2 mg/kg/day; Groups 2 and 3) as described in .

Article Title: The Effects of Irisin on Nω-Nitro-L-arginine Methyl Ester Hydrochloride-Induced Hypertension in Rats
Article Snippet: After one week, minipumps were replaced with ALZET 2ML2 osmotic minipumps containing saline for two weeks.

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92
    Durect Corporation alzet osmotic minipump
    Graphic depiction of the sequence of treatment and testing for experiments 1 and 2. In Experiment 1, an <t>Alzet</t> osmotic <t>minipump</t> was implanted into each rat, and drugs were administered starting on Day 0. The minipump was removed on Day 14, and the evaluation of either locomotor response to methamphetamine or the decapitation to evaluate D 2 receptor binding occurred on Day 21, ie, on the seventh day following treatment cessation. In Experiment 2, a minipump was implanted into each rat, and drugs were administered starting on Day 0; the first minipump was exchanged for a second minipump on Day 14. The second minipump was removed on Day 28, and the evaluation of either locomotor response to methamphetamine or the decapitation to evaluate D 2 receptor binding occurred on Day 35, ie, on the seventh day following the cessation of 2 consecutive treatment periods (total, 28 days). HAL indicates 0.75 mg/kg/d of haloperidol; ARI, 1.5 mg/kg/d of aripiprazole; and VEH, 2% glacial acetic acid/H 2 O solution as vehicle.
    Alzet Osmotic Minipump, supplied by Durect Corporation, used in various techniques. Bioz Stars score: 92/100, based on 303 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alzet osmotic minipump/product/Durect Corporation
    Average 92 stars, based on 303 article reviews
    Price from $9.99 to $1999.99
    alzet osmotic minipump - by Bioz Stars, 2020-07
    92/100 stars
      Buy from Supplier

    88
    Durect Corporation 2ml2 osmotic minipumps
    Graphic depiction of the sequence of treatment and testing for experiments 1 and 2. In Experiment 1, an <t>Alzet</t> osmotic <t>minipump</t> was implanted into each rat, and drugs were administered starting on Day 0. The minipump was removed on Day 14, and the evaluation of either locomotor response to methamphetamine or the decapitation to evaluate D 2 receptor binding occurred on Day 21, ie, on the seventh day following treatment cessation. In Experiment 2, a minipump was implanted into each rat, and drugs were administered starting on Day 0; the first minipump was exchanged for a second minipump on Day 14. The second minipump was removed on Day 28, and the evaluation of either locomotor response to methamphetamine or the decapitation to evaluate D 2 receptor binding occurred on Day 35, ie, on the seventh day following the cessation of 2 consecutive treatment periods (total, 28 days). HAL indicates 0.75 mg/kg/d of haloperidol; ARI, 1.5 mg/kg/d of aripiprazole; and VEH, 2% glacial acetic acid/H 2 O solution as vehicle.
    2ml2 Osmotic Minipumps, supplied by Durect Corporation, used in various techniques. Bioz Stars score: 88/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/2ml2 osmotic minipumps/product/Durect Corporation
    Average 88 stars, based on 3 article reviews
    Price from $9.99 to $1999.99
    2ml2 osmotic minipumps - by Bioz Stars, 2020-07
    88/100 stars
      Buy from Supplier

    Image Search Results


    Graphic depiction of the sequence of treatment and testing for experiments 1 and 2. In Experiment 1, an Alzet osmotic minipump was implanted into each rat, and drugs were administered starting on Day 0. The minipump was removed on Day 14, and the evaluation of either locomotor response to methamphetamine or the decapitation to evaluate D 2 receptor binding occurred on Day 21, ie, on the seventh day following treatment cessation. In Experiment 2, a minipump was implanted into each rat, and drugs were administered starting on Day 0; the first minipump was exchanged for a second minipump on Day 14. The second minipump was removed on Day 28, and the evaluation of either locomotor response to methamphetamine or the decapitation to evaluate D 2 receptor binding occurred on Day 35, ie, on the seventh day following the cessation of 2 consecutive treatment periods (total, 28 days). HAL indicates 0.75 mg/kg/d of haloperidol; ARI, 1.5 mg/kg/d of aripiprazole; and VEH, 2% glacial acetic acid/H 2 O solution as vehicle.

    Journal: Schizophrenia Bulletin

    Article Title: Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis

    doi: 10.1093/schbul/sbr006

    Figure Lengend Snippet: Graphic depiction of the sequence of treatment and testing for experiments 1 and 2. In Experiment 1, an Alzet osmotic minipump was implanted into each rat, and drugs were administered starting on Day 0. The minipump was removed on Day 14, and the evaluation of either locomotor response to methamphetamine or the decapitation to evaluate D 2 receptor binding occurred on Day 21, ie, on the seventh day following treatment cessation. In Experiment 2, a minipump was implanted into each rat, and drugs were administered starting on Day 0; the first minipump was exchanged for a second minipump on Day 14. The second minipump was removed on Day 28, and the evaluation of either locomotor response to methamphetamine or the decapitation to evaluate D 2 receptor binding occurred on Day 35, ie, on the seventh day following the cessation of 2 consecutive treatment periods (total, 28 days). HAL indicates 0.75 mg/kg/d of haloperidol; ARI, 1.5 mg/kg/d of aripiprazole; and VEH, 2% glacial acetic acid/H 2 O solution as vehicle.

    Article Snippet: These drugs were given via an Alzet osmotic minipump (model 2ML2; 14-day delivery; DURECT Corp.).

    Techniques: Sequencing, Binding Assay